Shirit Einav

Administrative Appointments

• Instructor of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine (2009 - present)
• Infectious Diseases Fellowship, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine (2004 - 2008)
• Postdoctoral Fellowship. Supervisor: Dr. Jeffrey S. Glenn, Division of Gastroenterology and Hepatology, Stanford University School of Medicine (2003 - 2004)
• Medical Internship and Residency, Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (1999 - 2002)
• Research Studentship, Supervisor: Dr. Michael C. Carroll., Brigham and Women’s Hospital and the Center for Blood Research, Harvard Medical School, Boston, MA (1999 - 1999)
View All 6administrative appointments of Shirit Einav

Honors and Awards

• Clinical Investigator Award (KO8), NIH/NIAID (Sept 2008 - July 2013)
• DDC Pilot/Feasibility Award, Stanford Digestive Disease Center (DDC) (March 2009)
• ITI Young Investigator Innovation Award, Stanford Institute for Immunity, Transplantation, and Infection (ITI) (Dec 2008)
• IDSA 2009 Program Committee Choice Award, Infectious Diseases Society of America (IDSA) (July 2009)
• American Liver Foundation Postdoctoral Fellowship Award, American Liver Foundation (ALF) (July 2006)

Professional Education

Web Site Links

• http://www.stanford.edu/~seinav/

Publications

• The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection. Einav S, Sklan EH, Moon HM, Gehrig E, Liu P, Hao Y, Lowe AW, Glenn JS. Hepatology. 2008; 47 (3): 827-35
• Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis. Einav S, Gerber D, Bryson PD, Sklan EH, Elazar M, Maerkl SJ, Glenn JS, Quake SR. Nat Biotechnol. 2008; 26 (9): 1019-27
• TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication. Sklan EH, Serrano RL, Einav S, Pfeffer SR, Lambright DG, Glenn JS. J Biol Chem. 2007; 282 (50): 36354-61
• Mechanisms of resistance to antiviral agents. Shafer RW, Einav S, Chou S. In Manual of clinical microbiology, 9th edition, Murray PR ed, Baron EJ ed, Jorgensen JH ed, Pfaller MA ed, Tenover FC ed, and Yolken RH ed. American Society of Microbiology.. 2007: 1689-04
• A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication. Einav S, Elazar M, Danieli T, Glenn JS. J Virol. 2004; 78 (20): 11288-95